Clinical Trial Update: A Study of Golimumab in Participants With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of golimumab in adults with active ankylosing spondylitis has completed, and results were posted in 2017. The study was sponsored by Jans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2017-11-13